AMN Healthcare Services (AMN) FY2013 results: revenue $1.0 billion, up 6.1% on the year
AMN Healthcare Services Inc. (AMN) reported revenue of $1.0 billion for fiscal 2013, the year ended 31 December 2013, up 6.1% on the year before. Net income was $33 million, up 92.2%, and diluted earnings per share $0.69. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2014.
Revenue
$1.0 billion
+6.1% on the year
FY2009FY2013
Operating margin
6.5%
5.6% a year earlier
FY2009FY2013
Net income
$33 million
+92.2% on the year
FY2009FY2013
Diluted EPS
$0.69
+86.5% on the year
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
1,012
954
887
+6.1%
Cost of revenue
715
684
638
+4.5%
Gross profit
297
270
249
+9.9%
Gross margin
29.4%
28.3%
28.1%
Selling, general and administrative
218
203
195
+7.6%
Operating income
65.5
53.3
37.6
+22.8%
Operating margin
6.5%
5.6%
4.2%
Interest expense
9.7
26.0
23.7
-62.9%
Pre-tax income
55.8
27.3
13.9
+104.4%
Income tax
22.9
11.0
8.9
+108.0%
Effective tax rate
41.0%
40.3%
64.0%
Net income
32.9
17.1
-26.3
+92.2%
Net margin
3.3%
1.8%
-3.0%
Diluted EPS
$0.69
$0.37
-$0.57
+86.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
60.2
58.4
19.3
+3.1%
Capital expenditure
9.0
5.5
4.6
+65.3%
Free cash flow
51.1
52.9
14.7
-3.4%
Free cash flow margin
5.1%
5.5%
1.7%
Cash from investing
-49.2
1.6
-2.0
Cash from financing
-1.0
-58.2
-15.3
Depreciation and amortisation
13.5
14.2
16.3
-4.3%
Share-based compensation
6.1
6.2
7.1
-1.5%
Diluted shares, weighted
48m
47m
46m
+2.3%
Shares outstanding at period end
46m
46m
40m
+0.7%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
218
182
136
+19.6%
Redeemable equity
n/a
0.0
24.1
Debt
159
160
205
-0.6%
Other liabilities
228
176
171
+29.7%
Total liabilities and equity
604
517
536
+16.8%
Fixed assets
21.2
14.8
16.9
+42.8%
Goodwill
145
123
123
+17.3%
Intangible assets
150
137
144
+9.7%
Cash and equivalents
15.6
5.7
4.0
+174.2%
Receivables
147
143
147
+3.5%
Other assets
125
94.1
101
+33.0%
Total assets
604
517
536
+16.8%
10-K for the year ended 31 December 2013, filed 21 February 2014: the filing.